Neuromyelitis optica following human papillomavirus vaccination

Neurology. 2012 Jul 17;79(3):285-7. doi: 10.1212/WNL.0b013e31825fdead. Epub 2012 Jun 20.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adverse Drug Reaction Reporting Systems
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Databases, Factual
  • Female
  • Humans
  • Immunoglobulin G / analysis
  • Magnetic Resonance Imaging
  • Medulla Oblongata / pathology
  • Methylprednisolone / therapeutic use
  • Muscle Weakness / etiology
  • Myelitis, Transverse / etiology
  • Myelitis, Transverse / therapy
  • Neuromyelitis Optica / etiology*
  • Papillomavirus Vaccines / adverse effects*
  • Paraparesis, Spastic / etiology
  • Plasma Exchange
  • Rituximab
  • Spinal Cord / pathology
  • Vaccination / adverse effects*
  • Vision Disorders / drug therapy
  • Vision Disorders / etiology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulin G
  • Papillomavirus Vaccines
  • Rituximab
  • Methylprednisolone